Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1244.20
9.60 (0.78%)
< Home < Back

Dr. Reddy's Laboratories informs about press release

Date: 27-01-2023
Dr. Reddy's Laboratories has informed that it enclosed Press Release on 'Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05% in the US Market'.

The above information is a part of company’s filings submitted to BSE.